openPR Logo
Press release

Phenylketonuria Market Value Projected to Expand by 2025

03-06-2018 04:49 PM CET | Health & Medicine

Press release from: Transparency Market Research

Phenylketonuria Market Value Projected to Expand by 2025

Phenylketonuria is a genetic disorder, which means it is inherited from one’s parents. In this disease, the patient suffers from a metabolic defect, wherein the body is unable to break down phenylalanine amino acid that is made of protein. Phenylalanine starts accumulating in the blood stream and eventually, it damages the brain. This happens due to mutations in the PAH gene, which result in low levels of the enzyme called phenylalanine hydroxylase. Intellectual impairment, hyperactivity, and mental health disorder are neurological symptoms of phenylketonuria.

Skin rashes and order on the skin are physiological symptoms of the disease. If both parents are carriers of PKU, there exists a 25% possibility that their child would be conceived with the confusion; a 50% possibility that the kid would be a transporter; and a 25% possibility that it would neither create nor transport the illness. The fundamental approach to treat PKU is to eat a special diet that cuts off the food containing phenylalanine. Newborn children with PKU can be fed with breast milk. They for the most part likewise need to expend an uncommon recipe known as Lofenalac. At the point of the time when the child has grown enough to eat solid food, giving it a chance to eat foods high in protein needs to be avoided.

Based on type, the Phenylketonuria Market has been segmented into classic PKU, mild PKU, and benign PKU. Moreover, classic PKU is most common type of phenylketonuria, which results in severe brain damage. Based on test, the phenylketonuria market has been divided into diagnostic test and screening test. The screening test segment is expanding at a rapid pace, as the screening test helps detect the disease at its earliest and most treatable stage, especially for the newborn baby. Based on treatment, the phenylketonuria market has been segmented into drug therapy, dietary therapy, gene therapy, and others.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32057

Furthermore, the drug therapy segment has been sub-divided into oral therapy and parenteral therapy. The drug therapy segment is expanding by holding a large market share, as external drugs such as sapropterin dihydrochloride are required to combat the disease. The drug therapy works effectively fulfilling the requirements and maintaining the phenylalanine level in the blood. The market for phenylketonuria in developed economies is witnessing growth, owing to the large number of patients suffering from phenylketonuria, high awareness about the disease, and high diagnostic rate of the disease in these countries. However, issues related to newborn screening is a factor that restricts the phenylketonuria market.

Based on geography, the global phenylketonuria market has been segmented into North America, Europe, Asia Pacific, Latin America, and MEA. The North America phenylketonuria treatment market is expected to hold a high market share during the forecast period, due to the rising number of newborns suffering from phenylketonuria in the region.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=32057

The rise in awareness among people and improved health care infrastructure in Europe boost the market in the region. The market in Asia Pacific is projected to expand at a significant rate during the forecast period, due to large pool of patients and increase in R&D activities for the development of drugs for phenylketonuria in the region. Moreover, growing economy and availability of newborn screening infrastructure and different screening programs augment the phenylketonuria market in Middle East & Africa.

Some of the key players operating in the global phenylketonuria market are American Gene Technologies International Inc., Dimension Therapeutics, Inc., BioMarin Pharmaceutical Inc., Synthetic Biologics, Inc., Codexis, Inc., SOM Innovation Biotech SL, Daiichi Sankyo Company, Limited, and Erytech Pharma SA.

View Report -

https://www.transparencymarketresearch.com/phenylketonuria.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Phenylketonuria Market Value Projected to Expand by 2025 here

News-ID: 967009 • Views: 498

More Releases from Transparency Market Research

Pad Printing Machine Market - Provides Veritable Information on Size, Growth Tre …
Pad Printing Machine Market: An Overview Need for an effective printing machine which can lay down simple one colored image or complex multicolor graphics to about every object helped in the introduction of pad printing machine. It is used to transfer a 2-D image via a silicon padon to a 3-D object on any type of surface like flat, spherical, irregular or cylindrical. Pad printing machine also prints photos or other
Varnished Cambric Tape Market - Company Strategy, Product Portfolio and Recent D …
Varnished cambric tape Market: An Overview The growth of renewable power generation will be an elementary factor to push the demand for the electrical wires and cables market across the globe, the countries are focusing more on power generation through renewable resources available in comparison with conventional (coal, thermal, etc.) power generation methodology, the transmission and distribution of electrical infrastructure is not only required to be completely developed in developed economies
Hip Flask Market | Reporting and Evaluation of Recent Industry Developments & Bu …
Hip Flask Market: An Overview Similar to the mobile, the hip flask started to appear in the form it was recognized today in the 18th century, the primarily hip flask was mainly used by the well-born people of high social class especially in the past. Initially, the hip flask was made of malleable metal alloy (Pewter), silver, gold, copper, and glass, but nowadays hip flask is also available in stainless steel
Cargo Pit Tape Market - Research Forecast, Revenue Opportunities And Sales Volum …
Cargo Pit Tape Market: An Overview The most important element in packaging is quality of adhesive to be used in packaged items to maintain the same quality throughout the supply chain till the time it reaches the destination safely. There are many types of packaging tapes available in the market with different applications. Polypropylene Tape: it’s economical, durable, and reliable and resistant to breaking or tearing during the shipping. Printed Fragile Tape: It

All 5 Releases


More Releases for PKU

Phenylketonuria (PKU) - Pipeline Review, H1 2018
"The Report Phenylketonuria (PKU) - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Phenylketonuria Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Phenylketonuria (PKU) - Pipeline Review, H1 2018, provides an overview of the Phenylketonuria (PKU) (Metabolic Disorders) pipeline landscape. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1509364 Phenylketonuria (also called PKU), is a
Phenylketonuria (PKU) Global Market Key Players – Biomarin, Vitaflo, Mead John …
Summary Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight. The global Phenylketonuria (PKU) market will reach xxx Million
Phenylketonuria (PKU) Market Size Share - Industry Trends by 2025
"The Latest Research Report Phenylketonuria (PKU) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Phenylketonuria is a genetic disorder, which means it is inherited from one’s parents. In this disease, the patient suffers from a metabolic defect, wherein the body is unable to break down phenylalanine amino acid
Phenylketonuria (PKU) is an inborn error of metabolism
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioural problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight. The scope
Phenylketonuria (PKU) Market Research Report : 2017
Reports And Markets Publish a New Market Research Report On –"Phenylketonuria (PKU) Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-phenylketonuria-pku-market-research-report-2017-1541147 In this report, the global Phenylketonuria (PKU) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions,
Phenylketonuria (PKU) - Market Insights, Epidemiology, Outlook to 2025
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Phenylketonuria (PKU)-Market Insights, Epidemiology and Market Forecast-2025” to its report offerings. The report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Phenylketonuria (PKU). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265871 The report provides an overview of the disease and in depth research related to Phenylketonuria (PKU) for the 7MM (United States,